FEHBP Premium "Call Letter" To Kick Off Hill Debate On Employee Program
Executive Summary
The role of pharmaceutical prices in the cost of the Federal Employees Health Benefit Program will return as a Capitol Hill issue following the release of the Office of Personnel Management's annual "call letter" on FEHBP premiums in early April.